Ticker
DNACompany Name
GINKGO BIOWORKS HOLDINGS INCSector
HealthcareIndustry
BiotechnologyExchange
NYSEDate | Gross Profit | Gross Margin | Revenues |
---|---|---|---|
6/30/2025 | $ 182.32M | 78.99% | $ 230.81M |
3/31/2025 | $ 190.02M | 80.04% | $ 237.42M |
12/31/2024 | $ 182.5M | 80.38% | $ 227.04M |
9/30/2024 | $ 176.41M | 80.94% | $ 217.95M |
6/30/2024 | $ 147.88M | 80.22% | $ 184.34M |
3/31/2024 | $ 167.87M | 80.43% | $ 208.7M |
12/31/2023 | $ 197.45M | 78.52% | $ 251.46M |
9/30/2023 | $ 237.37M | 75.36% | $ 314.99M |
6/30/2023 | $ 230.61M | 70.75% | $ 325.95M |
3/31/2023 | $ 248.84M | 63.81% | $ 390M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
GP / Revenues
(=) Gross %
Gross % for GINKGO BIOWORKS HOLDINGS INC is calculated as follows: GP [ $ 102.23M ] / Revenues [ $ 165.34M ]
(=) Gross % [ 61.83% ]
Minimum
Sep 30, 2022
Maximum
Sep 30, 2024
Average
Median
filtered constituents | 3.81K |
---|---|
min | -72.25% |
max | 150.26% |
average | 53.08% |
median | 49.45% |
std | 31.59% |